Back to Search
Start Over
High ENT1 and DCK gene expression levels are a potential biomarker to predict favorable response to nelarabine therapy in T-cell acute lymphoblastic leukemia.
- Source :
-
Hematological oncology [Hematol Oncol] 2019 Oct; Vol. 37 (4), pp. 516-519. Date of Electronic Publication: 2019 Aug 02. - Publication Year :
- 2019
- Subjects :
- Cell Line, Tumor
Humans
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma metabolism
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma pathology
Predictive Value of Tests
Arabinonucleosides pharmacology
Biomarkers, Tumor biosynthesis
Deoxycytidine Kinase biosynthesis
Equilibrative Nucleoside Transporter 1 biosynthesis
Gene Expression Regulation, Leukemic drug effects
Neoplasm Proteins biosynthesis
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1099-1069
- Volume :
- 37
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Hematological oncology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 31335977
- Full Text :
- https://doi.org/10.1002/hon.2654